Hydration and Structural Adaptations of the Human CYP1A1, CYP1A2, and CYP1B1 Active Sites by Molecular Dynamics Simulations.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
14 Jul 2023
Historique:
received: 29 06 2023
accepted: 11 07 2023
medline: 31 7 2023
pubmed: 29 7 2023
entrez: 29 7 2023
Statut: epublish

Résumé

Cytochromes CYP1A1, CYP1A2, and CYP1B1, the members of the cytochrome P450 family 1, catalyze the metabolism of endogenous compounds, drugs, and non-drug xenobiotics which include substances involved in the process of carcinogenesis, cancer chemoprevention, and therapy. In the present study, the interactions of three selected polymethoxy-trans-stilbenes, analogs of a bioactive polyphenol trans-resveratrol (3,5,4'-trihydroxy-trans-stilbene) with the binding sites of CYP1 isozymes were investigated with molecular dynamics (MD) simulations. The most pronounced structural changes in the CYP1 binding sites were observed in two substrate recognition sites (SRS): SRS2 (helix F) and SRS3 (helix G). MD simulations show that the number and position of water molecules occurring in CYP1 APO and in the structures complexed with ligands are diverse. The presence of water in binding sites results in the formation of water-protein, water-ligand, and bridging ligand-water-protein hydrogen bonds. Analysis of the solvent and substrate channels opening during the MD simulation showed significant differences between cytochromes in relation to the solvent channel and the substrate channels 2c, 2ac, and 2f. The results of this investigation lead to a deeper understanding of the molecular processes that occur in the CYP1 binding sites and may be useful for further molecular studies of CYP1 functions.

Identifiants

pubmed: 37511239
pii: ijms241411481
doi: 10.3390/ijms241411481
pmc: PMC10380238
pii:
doi:

Substances chimiques

Cytochrome P-450 CYP1A1 EC 1.14.14.1
Cytochrome P-450 CYP1A2 EC 1.14.14.1
Ligands 0
Cytochrome P-450 CYP1B1 EC 1.14.14.1
CYP1B1 protein, human EC 1.14.14.1
CYP1A2 protein, human EC 1.14.14.1
CYP1A1 protein, human EC 1.14.14.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Biochim Biophys Acta. 2016 Sep;1860(9):1821-35
pubmed: 27241846
J Chem Inf Model. 2010 Jun 28;50(6):1173-8
pubmed: 20462226
Oxid Med Cell Longev. 2020 Jan 3;2020:3028387
pubmed: 31998435
Bioinformatics. 2018 Oct 15;34(20):3586-3588
pubmed: 29741570
ChemMedChem. 2016 Oct 6;11(19):2102-2118
pubmed: 27551833
J Steroid Biochem Mol Biol. 2015 Mar;147:24-30
pubmed: 25448748
J Chem Inf Model. 2012 Dec 21;52(12):3155-68
pubmed: 23145473
J Chem Inf Model. 2018 Feb 26;58(2):350-361
pubmed: 29308882
Molecules. 2017 Jul 08;22(7):
pubmed: 28698457
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
Biochim Biophys Acta. 2007 Mar;1770(3):390-401
pubmed: 16920266
J Comput Chem. 2003 Oct;24(13):1549-62
pubmed: 12925999
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Drug Metab Dispos. 2020 Feb;48(2):86-92
pubmed: 31757797
J Biol Chem. 2013 May 3;288(18):12932-43
pubmed: 23508959
J Comput Chem. 2010 Mar;31(4):671-90
pubmed: 19575467
Protein J. 2014 Dec;33(6):536-48
pubmed: 25331835
Pharmacol Ther. 2013 Apr;138(1):103-41
pubmed: 23333322
Bioorg Med Chem. 2012 Sep 1;20(17):5117-26
pubmed: 22863525
Biotechnol Appl Biochem. 2013 Jan-Feb;60(1):134-45
pubmed: 23587001
Drug Metab Rev. 2016 Aug;48(3):434-52
pubmed: 27167388
Eur J Med Chem. 2021 Jan 1;209:112895
pubmed: 33069055
Int J Mol Sci. 2018 Mar 09;19(3):
pubmed: 29522491
PLoS Comput Biol. 2012;8(10):e1002708
pubmed: 23093919
J Biol Chem. 2020 Apr 24;295(17):5640-5653
pubmed: 32156703
J Chem Phys. 2020 Jul 28;153(4):044130
pubmed: 32752662
J Phys Chem B. 1998 Apr 30;102(18):3586-616
pubmed: 24889800
ACS Omega. 2021 Apr 19;6(17):11286-11296
pubmed: 34056284
J Biol Chem. 2007 May 11;282(19):14348-55
pubmed: 17311915
J Chem Inf Model. 2012 Dec 21;52(12):3144-54
pubmed: 23146088
Bioorg Med Chem. 2010 Sep 1;18(17):6310-5
pubmed: 20696580
Protein Eng Des Sel. 2008 Feb;21(2):91-100
pubmed: 18194981
J Biol Chem. 2018 Dec 14;293(50):19201-19210
pubmed: 30254074
Curr Opin Struct Biol. 2021 Apr;67:1-8
pubmed: 32942197
Bioinorg Chem Appl. 2018 Jul 25;2018:3924608
pubmed: 30147715
Drug Metab Dispos. 2022 Jan;50(1):49-57
pubmed: 34607808
Sci Rep. 2016 May 24;6:26536
pubmed: 27216779
Drug Discov Today. 2017 Feb;22(2):249-269
pubmed: 27890821
Chem Biol Drug Des. 2017 Dec;90(6):1226-1236
pubmed: 28632937
Sci Rep. 2021 Sep 23;11(1):18930
pubmed: 34556703
Expert Opin Drug Discov. 2019 Dec;14(12):1221-1225
pubmed: 31502891
Eur J Med Chem. 2020 Feb 1;187:111938
pubmed: 31830634
ACS Med Chem Lett. 2018 Oct 29;9(12):1247-1252
pubmed: 30613334
J Biol Chem. 2011 Feb 18;286(7):5736-43
pubmed: 21147782
J Mol Graph Model. 2017 Jun;74:326-336
pubmed: 28475969
Curr Drug Metab. 2012 Feb;13(2):177-89
pubmed: 22208532
Bioorg Med Chem. 2019 Jan 15;27(2):285-304
pubmed: 30553624
J Mol Recognit. 2016 Aug;29(8):370-90
pubmed: 26916064
J Chem Theory Comput. 2012 Sep 11;8(9):3257-3273
pubmed: 23341755
PLoS One. 2022 May 26;17(5):e0267162
pubmed: 35617319

Auteurs

Zbigniew Dutkiewicz (Z)

Department of Chemical Technology of Drugs, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznań, Poland.

Renata Mikstacka (R)

Department of Inorganic and Analytical Chemistry, Nicolaus Copernicus University, Collegium Medicum, Dr. A. Jurasza 2, 85-089 Bydgoszcz, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH